MedPath

To study the effect of Pavanari Rasa for pain management in Amavata.

Phase 2/3
Not yet recruiting
Conditions
Autoinflammatory syndromes. Ayurveda Condition: AMAVATAH,
Registration Number
CTRI/2023/07/055293
Lead Sponsor
National Institute of Ayurveda
Brief Summary

Participants attending the OPD and IPD of the NIA hospital and satisfying the selection criteria will

be selected. All the participants who voluntarily agree to participate and provide informed written

consent for participation will be recruited in the study.

Total 40 participants will be selected after details examination and divided in 2 group of 20 patients

each as per study protocol. All Procedures will be executed under aseptic condition .

The changes observed in the sign and symptoms will be assessed by adopting suitable

scoring method and the objective signs by using appropriate clinical tools- Baseline and weekly .

DAS-28 score  &  ESR  will be assessed on the Baseline and 15th day of the study .

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria
  • 1.Patients willing to sign consent form for the clinical trial.
  • 2.Patients between the age group of 25 to 60 years, irrespective of sex and socio-economic status.
  • 3.Patients having signs and symptoms of ‘Amavata’ (Rheumatoid Arthritis) 4.Patients fulfill the criteria of ACR / EULAR 2010 criteria (American College of Rheumatology /European League Against Rheumatism) 5.Patients with chronicity of less than 5 years.
Exclusion Criteria
  • 1.Patients having severe joint deformities.
  • 2.Patients having age < 20 years & > 60 years .
  • 3.Patients suffering from paralysis.
  • 4.Patients having any type of arthropathy such as Neoplasm of spine, Gout, Ankylosing spondylosis, Traumatic arthritis and Pyogenic osteomyelitis etc.
  • 5.Patients having associated Cardiac disease, Tuberculosis, Diabetes mellitus, Malignant Hypertension, Renal Function Impairment, Hypothyroidism, Rheumatic Heart Disease etc.
  • 6.Patients with extremely reduced joint space.
  • 7.Pregnant women and lactating mother.
  • 8.Patient taking disease modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in Pain score.14 days
Secondary Outcome Measures
NameTimeMethod
Changes in symptoms of Amavata, Improvement in quality of life and changes in DAS-28 score, CRP, RA Factor, Disability Index Score, other symptoms, Improvement in walking time,hand &foot grip.30 days

Trial Locations

Locations (1)

Hospital, National Institute of Ayurveda Deemed to be University Jaipur

🇮🇳

Jaipur, RAJASTHAN, India

Hospital, National Institute of Ayurveda Deemed to be University Jaipur
🇮🇳Jaipur, RAJASTHAN, India
DrTapaswini Dalasinghray
Principal investigator
7008756788
tapaswinidalasinghray@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.